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Titers and Hidden 
Leprosy Cases, 
Amazon Region
To the Editor: Leprosy remains 
a serious public health issue. Although 
the World Health Organization 
elimination target was achieved 
in 2000, with a prevalence of <1 
case/10,000 persons, despite progress 
since introduction of multidrug therapy 
(1), large pockets of poverty remain 
in which the disease is hyperendemic 
and underdiagnosed. In fact, in highly 
disease-endemic areas, the prevalence 
of previously undiagnosed leprosy 
cases in the general population has 
been reported to be 6× higher than the 
registered prevalence (2).
Most leprosy patients are in 
India and Brazil. In Brazil, new cases 
are concentrated in the Northeast, 
Midwest, and Amazon regions (from 
state capitals to the inner counties). 
Access to the health system is poor 
in these regions because of severe 
inequalities in the public health 
system of Brazil (3),
A total of 34,894 new cases were 
registered in Brazil during 2010 (4), 
corresponding to an incidence rate of 
18.22 cases per 100,000 population. 
Pará State accounted for 10.2% of 
cases (3,562 cases), an incidence rate 
of 46.93 per 100,000 population. When 
only children <15 years of age were 
considered, Pará registered 389 new 
cases of leprosy in 2010, representing 
10.9% of all cases, an incidence rate 
of 16.52 per 100,000 population. 
In Oriximiná, a county with 62,794 
inhabitants in northwestern Pará, ≈800 
km from Belém, Pará’s capital, a mean 
of 13.8 cases per year were registered 
for the past 5 years.
In 2010, in Oriximiná, we 
collected plasma samples from 138 
students 8–18 years of age, from 
35 leprosy patients who received 
a diagnosis during 2004–2009, 
and from 126 contacts of these 
patients (Federal University of 
Pará Research Ethics Committee 
protocol no. 197/07). We tested all 
of these samples for anti–phenolic 
glycolipid-I (PGL-I) IgM; 42% of 
students, 54.3% of case-patients, and 
45% of case-patient contacts were 
seropositive. In addition to collecting 
samples, we clinically examined the 
leprosy patients and their contacts, 
among whom we identifi ed 3 new 
leprosy cases. We did not examine 
students at that time. Contacts were 
persons from the same household 
or neighborhood whom the index 
case-patient described as a person 
with whom he or she had a close 
relationship. Leprosy cases were 
diagnosed in the fi eld on the basis 
of clinical signs, loss of sensation 
on the skin lesions, and presence 
of enlarged nerves. For operational 
reasons, skin smears were not 
performed. All cases were diagnosed 
by 2 leprologists. We used the Ridley-
Jopling classifi cation, associated with 
the indeterminate clinical type, as 
defi ned by the Madrid classifi cation. 
The ELISA cutoff for positive results 
was arbitrarily established as an 
optical density of 0.295 based on the 
average plus 3× the SD of the test 
results from 14 healthy persons from 
the Amazon region (5).
Because studies of the 
seroprevalence among contacts have 
reported a proportion of seropositive 
persons ranging from ≈1.9% to 
18.4% (6), we returned to Oriximiná 
16 months after the fi rst visit. We 
examined 2 groups of students and 
their contacts; 1 group was positive 
for anti–PGL-I, and the other group 
was negative for anti–PGL-I. We 
visited 44 households in 1 week. From 
the 35 leprosy patients encountered 
during the fi rst visit, we selected 25 
households to survey (14 with an 
anti–PGL-I–positive contact in the 
household and 11 without), and among 
students with results of anti–PGL-I 
serology, we selected 19 households 
(11 positive with an anti–PGL-I–
positive contact in the household and 
8 without). During our visits to all of 
these households, we examined 222 
persons (Table).
When we arrived in Oriximiná, 
only 2 cases had been registered 
in the national notifi able diseases 
information system. By using our 
approach, 23 new cases were found 
after we investigated households 
that had a person positive for 
anti–PGL-I (15 multibacillary, 8 
paucibacillary); we found only 7 new 
cases in households where residents 
were negative for anti–PGL-I (4 
multibacillary, 3 paucibacillary) 
(Table). For comparison, during the 
last traditional leprosy campaign in 
Oriximiná in 2008, eight new cases 
were detected. Furthermore, by using 
our strategy, the local public health 
service detected 9 additional new 
cases during the 4 months after our 
departure from Oriximiná.
These data emphasize that 
contact examination is crucial for 
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identifying new cases (7) and that 
such investigation must be conducted 
periodically. Our data also indicate 
that subclinical infections are highly 
prevalent among public school 
students in the Amazon region and 
that identifying students with positive 
anti–PGL-I test results can lead to 
discovery of new leprosy cases among 
students’ household contacts.
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Novel Prion Protein 
in BSE-affected 
Cattle, Switzerland
To the Editor: In a recent issue 
of Emerging Infectious Diseases, 
Seuberlich et al. (1) reported a 
novel prion protein in cattle with 
bovine spongiform encephalopathy 
(BSE). Two cows in Switzerland, 8 
and 15 years of age, tested positive 
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No. new cases 
Among persons 
previously tested
Among contacts of 
persons previously tested Total† 
Leprosy patients Positive 14 43 9 4 13 
Negative 11 42 1 1 2 
Students Positive 11 84 5 5 10 
Negative 8 53 1 4 5 
Total  44 222 16 14 30 
*Households were selected from among 35 leprosy patients encountered during the first visit (25 households, 14 with an anti–PGL-I–positive contact in 
the household and 11 without) and among students with results of anti–PGL-I serology (19 households, 11 with an anti–PGL-I–positive contact in the 
household and 8 without). PGL-I, phenolic glycolipid-I. 
†Fisher exact test comparing case-patients and non–case-patients among those positive or negative for anti-PGL-I IgM revealed a statistically significant 
difference (p = 0.0280). 
